Circulating β-atrial natriuretic factor in congestive heart failure in humans

C. M. Wei, P. C. Kao, J. T. Lin, D. M. Heublein, Hartzell V Schaff, John C Jr. Burnett

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background. β-Atrial natriuretic factor (β-ANF) is an antiparallel dimer of α-ANF (α-ANF) with diminished cyclic GMP generation in vitro. To date, the presence of β-ANF in the circulation of humans with severe congestive heart failure (CHF) remains controversial. The current study was designed to determine the presence and magnitude of circulating β-ANF in severe CHF, to correlate plasma β-ANF with the degree of ventricular dysfunction, and to investigate the role of human plasma and atrial tissue in the degradation of β-ANF. Methods and Results. Venous plasma samples were obtained from patients (n=12) with severe CHF and normal volunteers (n=8). Total plasma ANF was measured by radioimmunoassay. α-ANF and β-ANF in nonextracted plasma were separated by gel filtration chromatography using a P-6 column. Right atrial tissue samples (n=5) were collected from a different group of patients at the time of open-heart surgery. 125I β-ANF and I 125 ANF were incubated with atrial tissue or plasma. The corresponding peak areas of β- ANF were determined by Tamaya Digital Planimeter. β-ANF represented 61% of total plasma ANF in CHF patients and was not detected in normal human plasma. The elevation of β-ANF correlated with the severity of ventricular dysfunction. Thirty percent of β-ANF and 100% α-ANF were converted to smaller peptide fragments in atrial tissue with no conversion in plasma. Conclusions. β-ANF is the principal form of circulating ANF in patients with severe CHF and correlates with the degree of left ventricular dysfunction. β-ANF is not generated from α-ANF and may be degraded rapidly in atrial tissue to smaller peptide fragments that do not occur in plasma. As β-ANF is reported to have reduced biological action, the current studies may support the conclusion that the ANF system in CHF has reduced functional activity despite increases in circulation concentrations.

Original languageEnglish (US)
Pages (from-to)1016-1020
Number of pages5
JournalCirculation
Volume88
Issue number3
StatePublished - 1993

Fingerprint

Atrial Natriuretic Factor
Heart Failure
Ventricular Dysfunction
Peptide Fragments

Keywords

  • atrium
  • heart failure
  • natriuretic factors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Circulating β-atrial natriuretic factor in congestive heart failure in humans. / Wei, C. M.; Kao, P. C.; Lin, J. T.; Heublein, D. M.; Schaff, Hartzell V; Burnett, John C Jr.

In: Circulation, Vol. 88, No. 3, 1993, p. 1016-1020.

Research output: Contribution to journalArticle

Wei, CM, Kao, PC, Lin, JT, Heublein, DM, Schaff, HV & Burnett, JCJ 1993, 'Circulating β-atrial natriuretic factor in congestive heart failure in humans', Circulation, vol. 88, no. 3, pp. 1016-1020.
Wei, C. M. ; Kao, P. C. ; Lin, J. T. ; Heublein, D. M. ; Schaff, Hartzell V ; Burnett, John C Jr. / Circulating β-atrial natriuretic factor in congestive heart failure in humans. In: Circulation. 1993 ; Vol. 88, No. 3. pp. 1016-1020.
@article{7883498f0e8247569d74367b54769991,
title = "Circulating β-atrial natriuretic factor in congestive heart failure in humans",
abstract = "Background. β-Atrial natriuretic factor (β-ANF) is an antiparallel dimer of α-ANF (α-ANF) with diminished cyclic GMP generation in vitro. To date, the presence of β-ANF in the circulation of humans with severe congestive heart failure (CHF) remains controversial. The current study was designed to determine the presence and magnitude of circulating β-ANF in severe CHF, to correlate plasma β-ANF with the degree of ventricular dysfunction, and to investigate the role of human plasma and atrial tissue in the degradation of β-ANF. Methods and Results. Venous plasma samples were obtained from patients (n=12) with severe CHF and normal volunteers (n=8). Total plasma ANF was measured by radioimmunoassay. α-ANF and β-ANF in nonextracted plasma were separated by gel filtration chromatography using a P-6 column. Right atrial tissue samples (n=5) were collected from a different group of patients at the time of open-heart surgery. 125I β-ANF and I 125 ANF were incubated with atrial tissue or plasma. The corresponding peak areas of β- ANF were determined by Tamaya Digital Planimeter. β-ANF represented 61{\%} of total plasma ANF in CHF patients and was not detected in normal human plasma. The elevation of β-ANF correlated with the severity of ventricular dysfunction. Thirty percent of β-ANF and 100{\%} α-ANF were converted to smaller peptide fragments in atrial tissue with no conversion in plasma. Conclusions. β-ANF is the principal form of circulating ANF in patients with severe CHF and correlates with the degree of left ventricular dysfunction. β-ANF is not generated from α-ANF and may be degraded rapidly in atrial tissue to smaller peptide fragments that do not occur in plasma. As β-ANF is reported to have reduced biological action, the current studies may support the conclusion that the ANF system in CHF has reduced functional activity despite increases in circulation concentrations.",
keywords = "atrium, heart failure, natriuretic factors",
author = "Wei, {C. M.} and Kao, {P. C.} and Lin, {J. T.} and Heublein, {D. M.} and Schaff, {Hartzell V} and Burnett, {John C Jr.}",
year = "1993",
language = "English (US)",
volume = "88",
pages = "1016--1020",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Circulating β-atrial natriuretic factor in congestive heart failure in humans

AU - Wei, C. M.

AU - Kao, P. C.

AU - Lin, J. T.

AU - Heublein, D. M.

AU - Schaff, Hartzell V

AU - Burnett, John C Jr.

PY - 1993

Y1 - 1993

N2 - Background. β-Atrial natriuretic factor (β-ANF) is an antiparallel dimer of α-ANF (α-ANF) with diminished cyclic GMP generation in vitro. To date, the presence of β-ANF in the circulation of humans with severe congestive heart failure (CHF) remains controversial. The current study was designed to determine the presence and magnitude of circulating β-ANF in severe CHF, to correlate plasma β-ANF with the degree of ventricular dysfunction, and to investigate the role of human plasma and atrial tissue in the degradation of β-ANF. Methods and Results. Venous plasma samples were obtained from patients (n=12) with severe CHF and normal volunteers (n=8). Total plasma ANF was measured by radioimmunoassay. α-ANF and β-ANF in nonextracted plasma were separated by gel filtration chromatography using a P-6 column. Right atrial tissue samples (n=5) were collected from a different group of patients at the time of open-heart surgery. 125I β-ANF and I 125 ANF were incubated with atrial tissue or plasma. The corresponding peak areas of β- ANF were determined by Tamaya Digital Planimeter. β-ANF represented 61% of total plasma ANF in CHF patients and was not detected in normal human plasma. The elevation of β-ANF correlated with the severity of ventricular dysfunction. Thirty percent of β-ANF and 100% α-ANF were converted to smaller peptide fragments in atrial tissue with no conversion in plasma. Conclusions. β-ANF is the principal form of circulating ANF in patients with severe CHF and correlates with the degree of left ventricular dysfunction. β-ANF is not generated from α-ANF and may be degraded rapidly in atrial tissue to smaller peptide fragments that do not occur in plasma. As β-ANF is reported to have reduced biological action, the current studies may support the conclusion that the ANF system in CHF has reduced functional activity despite increases in circulation concentrations.

AB - Background. β-Atrial natriuretic factor (β-ANF) is an antiparallel dimer of α-ANF (α-ANF) with diminished cyclic GMP generation in vitro. To date, the presence of β-ANF in the circulation of humans with severe congestive heart failure (CHF) remains controversial. The current study was designed to determine the presence and magnitude of circulating β-ANF in severe CHF, to correlate plasma β-ANF with the degree of ventricular dysfunction, and to investigate the role of human plasma and atrial tissue in the degradation of β-ANF. Methods and Results. Venous plasma samples were obtained from patients (n=12) with severe CHF and normal volunteers (n=8). Total plasma ANF was measured by radioimmunoassay. α-ANF and β-ANF in nonextracted plasma were separated by gel filtration chromatography using a P-6 column. Right atrial tissue samples (n=5) were collected from a different group of patients at the time of open-heart surgery. 125I β-ANF and I 125 ANF were incubated with atrial tissue or plasma. The corresponding peak areas of β- ANF were determined by Tamaya Digital Planimeter. β-ANF represented 61% of total plasma ANF in CHF patients and was not detected in normal human plasma. The elevation of β-ANF correlated with the severity of ventricular dysfunction. Thirty percent of β-ANF and 100% α-ANF were converted to smaller peptide fragments in atrial tissue with no conversion in plasma. Conclusions. β-ANF is the principal form of circulating ANF in patients with severe CHF and correlates with the degree of left ventricular dysfunction. β-ANF is not generated from α-ANF and may be degraded rapidly in atrial tissue to smaller peptide fragments that do not occur in plasma. As β-ANF is reported to have reduced biological action, the current studies may support the conclusion that the ANF system in CHF has reduced functional activity despite increases in circulation concentrations.

KW - atrium

KW - heart failure

KW - natriuretic factors

UR - http://www.scopus.com/inward/record.url?scp=0027265434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027265434&partnerID=8YFLogxK

M3 - Article

C2 - 8353863

AN - SCOPUS:0027265434

VL - 88

SP - 1016

EP - 1020

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -